Company intelligence / Profile preview
Organogenesis
Canton, Massachusetts, United Statesorganogenesis.com ↗
- Ownership
- Public · ORGO
- Employees
- ~862
- Development stage
- Other
01
Overview
Organogenesis has established itself as a leader in regenerative medicine with multiple FDA-approved products for advanced wound care. Its flagship product Apligraf® was the first living cell therapy approved by the FDA to treat both diabetic foot ulcers and venous leg ulcers. The company’s portfolio includes several commercialized products addressing acute/chronic wounds and surgical needs. It also has an advanced pipeline with ReNu in Phase III trials targeting knee osteoarthritis.
- Therapeutic areas
- DermatologyEndocrinologyOtherRheumatologyCardiovascular
- Modalities
- Living cell-based therapies (e.g., Apligraf®, Dermagraft®)Allogeneic tissue matrices (e.g., NuShield®, Affinity®)Antimicrobial wound matrices (e.g., PuraPly® AM)Injectable biologics (e.g., ReNu)
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
03
Partnerships
Strategic partnerships not specifically listed; company collaborates broadly across hospitals, clinics, government facilities.
04
Financials
- Market cap
- $108.1M
- Total revenue
- $563M
- Enterprise value
- $151.3M
Beyond the preview
Go deeper on Organogenesis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Organogenesis.